These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 27785783)

  • 1. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
    Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
    Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
    Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
    Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
    Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
    Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
    Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
    Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes.
    Gil-Julio H; Perea F; Rodriguez-Nicolas A; Cozar JM; González-Ramirez AR; Concha A; Garrido F; Aptsiauri N; Ruiz-Cabello F
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional CD8+ T cells infiltrate into nonsmall cell lung carcinoma.
    Verdegaal EM; Hoogstraten C; Sandel MH; Kuppen PJ; Brink AA; Claas FH; Gorsira MC; Graadt van Roggen JF; Osanto S
    Cancer Immunol Immunother; 2007 May; 56(5):587-600. PubMed ID: 16924494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
    Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
    J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.
    Kataki A; Scheid P; Piet M; Marie B; Martinet N; Martinet Y; Vignaud JM
    J Lab Clin Med; 2002 Nov; 140(5):320-8. PubMed ID: 12434133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Cell Composition in Human Non-small Cell Lung Cancer.
    Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Front Immunol; 2018; 9():3101. PubMed ID: 30774636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival.
    Lou Y; Vitalis TZ; Basha G; Cai B; Chen SS; Choi KB; Jeffries AP; Elliott WM; Atkins D; Seliger B; Jefferies WA
    Cancer Res; 2005 Sep; 65(17):7926-33. PubMed ID: 16140964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
    Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
    Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors.
    Patel SS; Nota SP; Sabbatino F; Nielsen GP; Deshpande V; Wang X; Ferrone S; Schwab JH
    Clin Orthop Relat Res; 2021 Jun; 479(6):1373-1382. PubMed ID: 33273248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
    Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
    J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
    Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
    Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
    Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
    Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.
    de Groot AF; Blok EJ; Charehbili A; Engels CC; Smit VTHBM; Dekker-Ensink NG; Putter H; Meershoek-Klein Kranenbarg E; van de Velde CJH; Liefers GJ; Nortier JWR; Kuppen PJK; van der Burg SH; Kroep JR
    Breast Cancer Res Treat; 2019 Jun; 175(3):605-615. PubMed ID: 30868392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
    Redondo M; Ruiz-Cabello F; Concha A; Cabrera T; Pérez-Ayala M; Oliva MR; Garrido F
    Cancer Res; 1991 May; 51(9):2463-8. PubMed ID: 1849792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.